UK Markets close in 15 mins

Magellan Health, Inc. (MGLN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
94.99+94.99 (0.00%)
As of 04:00PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.04
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 399.36
52-week low 382.94
50-day moving average 394.68
200-day moving average 394.47

Share statistics

Avg vol (3-month) 3143.02k
Avg vol (10-day) 3200.95k
Shares outstanding 526.33M
Implied shares outstanding 6N/A
Float 823.55M
% held by insiders 11.64%
% held by institutions 1102.61%
Shares short (14 Dec 2021) 41.16M
Short ratio (14 Dec 2021) 49.84
Short % of float (14 Dec 2021) 45.71%
Short % of shares outstanding (14 Dec 2021) 44.40%
Shares short (prior month 14 Nov 2021) 41.53M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 6.26%
Operating margin (ttm)0.60%

Management effectiveness

Return on assets (ttm)0.54%
Return on equity (ttm)-0.16%

Income statement

Revenue (ttm)4.82B
Revenue per share (ttm)185.18
Quarterly revenue growth (yoy)7.20%
Gross profit (ttm)120.79M
EBITDA 86.76M
Net income avi to common (ttm)-7.8M
Diluted EPS (ttm)11.19
Quarterly earnings growth (yoy)-49.00%

Balance sheet

Total cash (mrq)1.01B
Total cash per share (mrq)38.44
Total debt (mrq)562.64M
Total debt/equity (mrq)28.51
Current ratio (mrq)2.92
Book value per share (mrq)73.44

Cash flow statement

Operating cash flow (ttm)185.41M
Levered free cash flow (ttm)689.85M